151 related articles for article (PubMed ID: 18710393)
1. Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma.
Rodriguez FJ; Mota RA; Scheithauer BW; Giannini C; Blair H; New KC; Wu KJ; Dickson DW; Jenkins RB
Brain Pathol; 2009 Oct; 19(4):623-9. PubMed ID: 18710393
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms.
Singh VY; Chacko G; Chacko AG; Rajshekhar V
Neurol India; 2014; 62(1):32-6. PubMed ID: 24608451
[TBL] [Abstract][Full Text] [Related]
3. Dural metastasis of atypical extraventricular neurocytoma with the codeletion of chromosomes 1p/19q.
Wang L; Chen G; Wei H; Liu F; Hu H; Zhang J
J Int Med Res; 2011; 39(5):2020-6. PubMed ID: 22118007
[TBL] [Abstract][Full Text] [Related]
4. Atypical extraventricular neurocytoma with oligodendroglioma-like spread and an unusual pattern of chromosome 1p and 19q loss.
Mrak RE; Yasargil MG; Mohapatra G; Earel J; Louis DN
Hum Pathol; 2004 Sep; 35(9):1156-9. PubMed ID: 15343519
[TBL] [Abstract][Full Text] [Related]
5. Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.
Griffin CA; Burger P; Morsberger L; Yonescu R; Swierczynski S; Weingart JD; Murphy KM
J Neuropathol Exp Neurol; 2006 Oct; 65(10):988-94. PubMed ID: 17021403
[TBL] [Abstract][Full Text] [Related]
6. 1p19q LOH patterns and expression of p53 and Olig2 in gliomas: relation with histological types and prognosis.
Durand KS; Guillaudeau A; Weinbreck N; DeArmas R; Robert S; Chaunavel A; Pommepuy I; Bourthoumieu S; Caire F; Sturtz FG; Labrousse FJ
Mod Pathol; 2010 Apr; 23(4):619-28. PubMed ID: 20081802
[TBL] [Abstract][Full Text] [Related]
7. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
8. [Influence of molecular-genetic factors on prognosis in patients with oligodendroglial tumors].
Absaliamova OV; Korshunov AG; Loshakov VA; Kobiakov GL; Golanov AV; Urakov SV; Amanov RD; Lichinitser MR
Zh Vopr Neirokhir Im N N Burdenko; 2009; (1):17-23; discussion 23-4. PubMed ID: 19507310
[TBL] [Abstract][Full Text] [Related]
9. A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.
Jenkins RB; Blair H; Ballman KV; Giannini C; Arusell RM; Law M; Flynn H; Passe S; Felten S; Brown PD; Shaw EG; Buckner JC
Cancer Res; 2006 Oct; 66(20):9852-61. PubMed ID: 17047046
[TBL] [Abstract][Full Text] [Related]
10. FISHing for 1p19q codel in oligodendroglioma.
Kong PL; Cheah PL; Mun KS; Chiew SF; Lau TP; Koh CC; Teoh KH; Nazarina AR; Looi LM
Malays J Pathol; 2020 Dec; 42(3):369-376. PubMed ID: 33361717
[TBL] [Abstract][Full Text] [Related]
11. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors.
Fujisawa H; Marukawa K; Hasegawa M; Tohma Y; Hayashi Y; Uchiyama N; Tachibana O; Yamashita J
J Neurosurg; 2002 Dec; 97(6):1350-5. PubMed ID: 12507133
[TBL] [Abstract][Full Text] [Related]
12. Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma.
Mut M; Güler-Tezel G; Lopes MB; Bilginer B; Ziyal I; Ozcan OE
Clin Neuropathol; 2005; 24(5):225-9. PubMed ID: 16167546
[TBL] [Abstract][Full Text] [Related]
13. Central neurocytomas are genetically distinct from oligodendrogliomas and neuroblastomas.
Tong CY; Ng HK; Pang JC; Hu J; Hui AB; Poon WS
Histopathology; 2000 Aug; 37(2):160-5. PubMed ID: 10931240
[TBL] [Abstract][Full Text] [Related]
14. Can oligodendrocyte transcriptional factor-2 (Olig2) be used as an alternative for 1p/19q co-deletions to distinguish oligodendrogliomas from other glial neoplasms?
Kurdi M; Alkhatabi H; Butt N; Albayjani H; Aljhdali H; Mohamed F; Alsinani T; Baeesa S; Almuhaini E; Al-Ghafari A; Hakamy S; Faizo E; Bahakeem B
Folia Neuropathol; 2021; 59(4):350-358. PubMed ID: 35114775
[TBL] [Abstract][Full Text] [Related]
15. FISHing Tips: What Every Clinician Should Know About 1p19q Analysis in Gliomas Using Fluorescence in situ Hybridisation.
Pinkham MB; Telford N; Whitfield GA; Colaco RJ; O'Neill F; McBain CA
Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):445-53. PubMed ID: 25971646
[TBL] [Abstract][Full Text] [Related]
16. Extraventricular neurocytoma and ganglioneurocytoma: advanced MR imaging, histopathological, and chromosomal findings.
Nabavizadeh SA; Chawla S; Baccon J; Zhang PJ; Poptani H; Melhem ER; Vossough A
J Neuroimaging; 2014; 24(6):613-616. PubMed ID: 24787229
[TBL] [Abstract][Full Text] [Related]
17. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.
Perry A; Fuller CE; Banerjee R; Brat DJ; Scheithauer BW
Front Biosci; 2003 Jan; 8():a1-9. PubMed ID: 12456321
[TBL] [Abstract][Full Text] [Related]
18. Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours.
Kim JW; Park CK; Park SH; Kim YH; Han JH; Kim CY; Sohn CH; Chang KH; Jung HW
J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):224-7. PubMed ID: 20587495
[TBL] [Abstract][Full Text] [Related]
19. Conventional Magnetic Resonance Features for Predicting 1p19q Codeletion Status of World Health Organization Grade II and III Diffuse Gliomas.
Peng X; Yishuang C; Kaizhou Z; Xiao L; Ma C
J Comput Assist Tomogr; 2019; 43(2):269-276. PubMed ID: 30371623
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients.
Rodriguez FJ; Tihan T; Lin D; McDonald W; Nigro J; Feuerstein B; Jackson S; Cohen K; Burger PC
Am J Surg Pathol; 2014 Aug; 38(8):1058-70. PubMed ID: 24805856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
